Amgen takes 20% stake in Chinese biotech BeiGene for $2.7 billion - Abilitify

October 31, 2019 abilitify 0 Comments

Under the all-cash deal, Amgen will pay BeiGene shareholders $174.85 per share, a 25% premium to BeiGene’s closing price on the Nasdaq on Wednesday.

Tags: crm erp Startups